Is the Prescription Opioid Epidemic a White Problem?

Economists Anne Case and Angus Deaton report that the life expectancy of US White persons has declined,1 largely as a result of drug overdose in the context of increased opioid analgesic use. An underacknowledged cause for this racial pattern is opioid regulation and marketing, which gave US White p...

Full description

Saved in:

Bibliographic Details
Published in:	American journal of public health (1971) 2016-12, Vol.106 (12), p.2127-2129
Main Authors:	Hansen, Helena, Netherland, Julie
Format:	Article
Language:	eng
Subjects:	Access to Care African Americans - statistics & numerical data AJPH s Analgesics, Opioid - adverse effects Cocaine Community Health Drug abuse Drug addiction Drug overdose Drugs Epidemics European Continental Ancestry Group - statistics & numerical data FDA approval Forecasting Government Harm reduction Health Policy - legislation & jurisprudence Heroin Hispanic Americans Hispanic Americans - statistics & numerical data Humans Imprisonment Inequality Law enforcement Life expectancy Life Expectancy - trends Marketing Methadone Mortality Narcotics Neurosciences Opioid-Related Disorders - epidemiology Opioid-Related Disorders - etiology Other Race/Ethnicity Pain Physicians Prescription drugs Prescription Drugs - adverse effects Public health Race Racial differences Substance abuse treatment United States - epidemiology White people
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Economists Anne Case and Angus Deaton report that the life expectancy of US White persons has declined,1 largely as a result of drug overdose in the context of increased opioid analgesic use. An underacknowledged cause for this racial pattern is opioid regulation and marketing, which gave US White patients the ?privilege? of unparalleled access to prescription opioids, illustrating how racially disparate drug policies and health care practices ultimately hurt White patients.
ISSN:	0090-0036 1541-0048